Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole for Acid-Induced Pulmonary Inflammation
NCT00361972Phase 3Terminated
- Sponsor
- University of Utah
- Start
- Aug 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gastroesophageal reflux disease (GERD) and asthma comparing Lansoprazole therapy with Placebo (2 arms). Primary endpoint: Change in Lymphocyte Count at 6 weeks. Started Aug 2006; status: terminated.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)asthma
Beyond the preview
Go deeper on NCT00361972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00361972.